We love the excitement & results from the community on AlphaFold 3 and are doubling the AF Server daily job limit to 20. Happy to also share that we're working on releasing the AF3 model (incl weights) for academic use, which doesn’t depend on our research infra, within 6 months.

Since 2016 I've been told that "self-play" was going to be a huge thing in AI. With the rise of AI girlfriends, it might finally become true.

They literally made a Convolutional Neural Network in Minecraft before we got GPT-5.

We investigated AlphaFold3 against RoseTTAfold-AllAtom and a new variant of Metal3D for prediction of metal-protein complexes. Tl;dr AlphaFold3 is as good as specialized tools on metal ion prediction. RFAA not so much. Some interesting findings in below thread: 1/

We’re presenting AlphaProteo: an AI system for designing novel proteins that bind more successfully to target molecules. 🧬 It could help scientists better understand how biological systems function, save time in research, advance drug design and more. 🧵 dpmd.ai/3XuMqbX

Our Chief AI Officer @MaxJaderberg spoke with Forbes writer Sai Balasubramanian, M.D., J.D. about the significance of AlphaFold 3 in advancing rational drug design at Isomorphic Labs, read more here: bit.ly/4d4mlFb

BREAKING NEWS The Royal Swedish Academy of Sciences has decided to award the 2024 #NobelPrize in Physics to John J. Hopfield and Geoffrey E. Hinton “for foundational discoveries and inventions that enable machine learning with artificial neural networks.”

Well-deserved recognition for the incredible work of AlphaFold + AI protein design!! It has been hugely inspiring to see the vision & potential of applying AI for science since joining Isomorphic Labs two months ago - let's get the Medicine prize next Demis Hassabis :D

We are thrilled to share the breaking news that our CEO and founder Demis Hassabis and Google DeepMind colleague John Jumper have been awarded the 2024 Nobel Prize in Chemistry for their groundbreaking work creating AlphaFold alongside David Baker for computational protein

Winning the The Nobel Prize is the honour of a lifetime and the realisation of a lifelong dream - it still hasn’t really sunk in yet. With AlphaFold2 we cracked the 50-year grand challenge of protein structure prediction: predicting the 3D structure of a protein purely from its

Calling ML research engineers, we are hiring! Expedite the process by meeting the hiring managers joanna, Marco Fiscato & Oliver Osborne at NeurIPS Conference 2024. Learn more about the opportunity here: bit.ly/40Vo4tR #ai #drugdiscovery #NeurIPS2024

I'm (finally!) going to be at NeurIPS Conference next week -Come chat with me and the rest of the team at Isomorphic Labs - join us to work on the next "AlphaFold" moment in our journey to accelerate drug discovery 🚀 bit.ly/40Vo4tR

NEW: A look inside Isomorphic Labs, the startup trying to change how drugs are discovered with AI. I spent time with Demis Hassabis and other Iso leaders in their London headquarters. Here's my exclusive feature on what they're up to: endpts.com/isomorphic-lab…

We are excited to announce the expansion of our collaboration with Novartis, doubling the number of research programs just over a year after initiating our partnership. This expansion is testament to the great progress we’ve made together and further unlocks the potential to

Meet us at ICLR 2025! We’ll be in Singapore from April 23, come interview for our open roles at Isomorphic Labs. Register here: rsvp.withgoogle.com/events/isomorp… #ICLR2025

“The future of biology won’t be siloed—it will be collaborative, interdisciplinary, and deeply creative. Demis is helping us get there faster.” We’re thrilled to see our CEO, Demis Hassabis, recognised as one of TIME’s 100 Most Influential People in the world. In this feature,

FutureHouse's goal has been to automate scientific discovery. Now we used our agents to make a genuine discovery – a new treatment for one kind of blindness (dAMD). We had multiple cycles of hypotheses, experiments, and data analysis – including identify the mechanism of action.

The ambition at Isomorphic Labs is immense – they’re rethinking drug discovery from the ground up, using AI. 💊 Join Head of Medicinal Drug Design rebecca paul & Chief AI Officer Max Jaderberg as they share the possibilities of AI in tackling disease with host @fryrsquared.

We are thrilled to support the UK’s new #OpenBind consortium, a government-backed initiative to create the world’s largest open dataset for AI drug discovery.

We're excited to welcome Dr. Ben Wolf, M.D., Ph.D., as our new Chief Medical Officer at Isomorphic Labs! Dr. Wolf brings nearly 20 years of biopharmaceutical experience to the team, and will be based in our new Cambridge, Massachusetts location as we advance therapeutic programs